FMP
Mainz Biomed B.V.
MYNZ
NASDAQ
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
0.905 USD
0.0008 (0.0884%)
About
ceo
Mr. Guido Baechler
sector
Healthcare
industry
Medical - Diagnostics & Research
website
https://mainzbiomed.com
exchange
NASDAQ
Description
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
CIK
0001874252
ISIN
NL0015000LC2
CUSIP
N5436L101
Address
Robert Koch Strasse 50
Phone
49 6131 554 2860
Country
DE
Employee
65
IPO Date
Nov 5, 2021
Summary
CIK
0001874252
Exchange
NASDAQ
Industry
Medical - Diagnostic...
Sector
Healthcare
CUSIP
N5436L101
ISIN
NL0015000LC2
Country
DE
Price
0.91
Beta
0.24
Volume Avg.
83.77k
Market Cap
15.16M
Shares
-
52-Week
0.85-6.0
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.56
P/B
-
Website
https://mainzbiomed.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest MYNZ News
It looks like there's no news available.
